Ovarian Mucinous Cystadenocarcinoma
specificAn invasive cystic adenocarcinoma arising from the ovary. It is characterized by the presence of malignant glandular epithelial cells which contain intracytoplasmic mucin. The malignant cells invade the ovarian stroma and the cystic spaces contain mucoid material. In a minority of cases both ovaries are involved by the tumor. The prognosis for stage I tumors is excellent. Patients with metastases usually have a poor prognosis.
46
Centers
38
Active Trials
—
Cancer Funding
Top Centers for Ovarian Mucinous Cystadenocarcinoma(46)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive High-Volume Research Center | 72.1 |
| 2 | NCI Comprehensive High-Volume Research Center | 72.1 |
| 3 | University of Illinois Cancer CenterChicago, IL High-Volume Research Center | 72.1 |
| 4 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 55.0 |
| 5 | UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive Active Research Program | 55.0 |
| 6 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 55.0 |
| 7 | NCI Comprehensive Active Research Program | 55.0 |
| 8 | Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program | 55.0 |
| 9 | NCI Comprehensive Active Research Program | 55.0 |
| 10 | NCI Comprehensive Active Research Program | 55.0 |
| 11 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 55.0 |
| 12 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program | 55.0 |
| 13 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 55.0 |
| 14 | Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive Active Research Program | 55.0 |
| 15 | UF Health Cancer InstituteGainesville, FL NCI Clinical Active Research Program | 55.0 |
| 16 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 55.0 |
| 17 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program | 55.0 |
| 18 | Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program | 55.0 |
| 19 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 55.0 |
| 20 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program | 55.0 |
| 21 | University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical Active Research Program | 55.0 |
| 22 | University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive Active Research Program | 55.0 |
| 23 | UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR Active Research Program | 55.0 |
| 24 | Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive Active Research Program | 55.0 |
| 25 | Boston University Cancer CenterBoston, MA Active Research Program | 55.0 |
| 26 | Active Research Program | 55.0 |
| 27 | Cancer Center at IllinoisUrbana, IL Active Research Program | 55.0 |
| 28 | Stony Brook Cancer CenterStony Brook, NY Active Research Program | 55.0 |
| 29 | University of Cincinnati Cancer CenterCincinnati, OH Active Research Program | 55.0 |
| 30 | Georgia Cancer Center, Augusta UniversityAugusta, GA Active Research Program | 55.0 |
| 31 | Upstate Cancer CenterSyracuse, NY Active Research Program | 55.0 |
| 32 | University of Texas Medical Branch Cancer CenterGalveston, TX Active Research Program | 55.0 |
| 33 | BC CancerVancouver, BC Active Research Program | 55.0 |
| 34 | Princess Margaret Cancer CentreToronto, ON Active Research Program | 55.0 |
| 35 | Louisiana Cancer Research CenterNew Orleans, LA Active Research Program | 55.0 |
| 36 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive | 34.0 |
| 37 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive | 34.0 |
| 38 | Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive | 34.0 |
| 39 | Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive | 34.0 |
| 40 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive | 34.0 |
| 41 | UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive | 34.0 |
| 42 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive | 34.0 |
| 43 | Cedars-Sinai CancerLos Angeles, CA | 34.0 |
| 44 | Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive | 34.0 |
| 45 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive | 34.0 |
| 46 | Dartmouth Cancer CenterLebanon, NH NCI Comprehensive | 34.0 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →